Anti-KCNK7/ K2p7.1/ TWIK3 monoclonal antibody

Anti-KCNK7/ K2p7.1/ TWIK3 antibody for FACS & in-vivo assay

Target products collectionGo to KCNK7/KCNK7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0685-Ab-1/ GM-Tg-hg-MP0685-Ab-2Anti-Human KCNK7 monoclonal antibodyHuman
GM-Tg-rg-MP0685-Ab-1/ GM-Tg-rg-MP0685-Ab-2Anti-Rat KCNK7 monoclonal antibodyRat
GM-Tg-mg-MP0685-Ab-1/ GM-Tg-mg-MP0685-Ab-2Anti-Mouse KCNK7 monoclonal antibodyMouse
GM-Tg-cynog-MP0685-Ab-1/ GM-Tg-cynog-MP0685-Ab-2Anti-Cynomolgus/ Rhesus macaque KCNK7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0685-Ab-1/ GM-Tg-felg-MP0685-Ab-2Anti-Feline KCNK7 monoclonal antibodyFeline
GM-Tg-cang-MP0685-Ab-1/ GM-Tg-cang-MP0685-Ab-2Anti-Canine KCNK7 monoclonal antibodyCanine
GM-Tg-bovg-MP0685-Ab-1/ GM-Tg-bovg-MP0685-Ab-2Anti-Bovine KCNK7 monoclonal antibodyBovine
GM-Tg-equg-MP0685-Ab-1/ GM-Tg-equg-MP0685-Ab-2Anti-Equine KCNK7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0685-Ab-1/ GM-Tg-hg-MP0685-Ab-2; GM-Tg-rg-MP0685-Ab-1/ GM-Tg-rg-MP0685-Ab-2;
GM-Tg-mg-MP0685-Ab-1/ GM-Tg-mg-MP0685-Ab-2; GM-Tg-cynog-MP0685-Ab-1/ GM-Tg-cynog-MP0685-Ab-2;
GM-Tg-felg-MP0685-Ab-1/ GM-Tg-felg-MP0685-Ab-2; GM-Tg-cang-MP0685-Ab-1/ GM-Tg-cang-MP0685-Ab-2;
GM-Tg-bovg-MP0685-Ab-1/ GM-Tg-bovg-MP0685-Ab-2; GM-Tg-equg-MP0685-Ab-1/ GM-Tg-equg-MP0685-Ab-2
Products NameAnti-KCNK7 monoclonal antibody
Formatmab
Target NameKCNK7
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KCNK7 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species KCNK7/ K2p7.1/ TWIK3 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0685
    Target NameKCNK7
    Gene ID10089,16530,499303,716087,483733,101096353,532497,100051469
    Gene Symbol and Synonyms2310014G03Rik,K2p7.1,Kcnk6,KCNK7,Kcnk8,Knot,Mlk3,RGD1565025,TWIK3
    Uniprot AccessionQ9Y2U2
    Uniprot Entry NameKCNK7_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000173338
    Target ClassificationIon Channel

    The target: KCNK7, gene name: KCNK7, also named as K2p7.1, TWIK3. This gene encodes a member of the superfamily of potassium channel proteins containing two pore-forming P domains. The product of this gene has not been shown to be a functional channel; however, it may require other non-pore-forming proteins for activity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.